Home Is Diethylcarbamazine citrate an antibiotic?|Off-topic Stuff|Forum|SNES HUB

Is Diethylcarbamazine citrate an antibiotic?|Off-topic Stuff|Forum|SNES HUB

A A A
Please consider registering
guest
sp_LogInOut Log Insp_Registration Register

Register | Lost password?
sp_Search Search
Advanced Search
Advanced Search
Forum Scope


Match



Forum Options



Minimum search word length is 3 characters - maximum search word length is 84 characters
sp_Search Search
Go to Bottom
sp_Feed Topic RSSsp_TopicIcon
Is Diethylcarbamazine citrate an antibiotic?
August 14, 2024
2:17 am
davidbrownm05
Member
Members
Forum Posts: 3
Member Since:
June 26, 2024
sp_UserOfflineSmall Offline
Go to Top
1sp_Permalink sp_Print
No, Diethylcarbamazine citrate is not an antibiotic.

Antibiotics are medications used to treat bacterial infections. Diethylcarbamazine citrate, on the other hand, is an anthelmintic. This means it’s specifically designed to kill parasitic worms, not bacteria. It’s used to treat various worm infections like filariasis, which cause conditions such as river blindness and lymphatic filariasis. diethylcarbamazine over the counter is available at dosepharmacy 

Diethylcarbamazine Citrate (DEC)

  • Anthelmintic: Kills parasitic worms.
  • Treats: Filariasis (river blindness, lymphatic filariasis).
  • Mechanism: Disrupts worm’s muscle and nerve function.
  • Administration: Oral tablets.
  • Side effects: Dizziness, nausea, headache, fatigue, rash.
  • Interactions: Can interact with other medications.
  • Contraindications: Pregnancy, breastfeeding, liver disease, certain eye conditions.
sp_Feed All RSS
Go to top
Forum Timezone: America/New_York
Most Users Ever Online: 812
Currently Online: leoparker
Guest(s) 107
Currently Browsing this Page:
1 Guest(s)
Top Posters:
GhostSweeper: 909
Mongunzoo: 816
RushDawg: 811
Member Stats:
Guest Posters: 1
Members: 22363
Moderators: 0
Admins: 1
Forum Stats:
Groups: 3
Forums: 12
Topics: 15462
Posts: 28680
Newest Members:
AdamWilliams2346, agemianlawgroup
Administrators: Masamune: 1574

Comments are closed.